Health care spending growth in Canada slowing, says CIHI

30 October 2012

Total health care spending in Canada is expected to reach C$207 billion ($207.62 billion) in 2012, averaging C$5,948 per person. The figures in National Health Expenditure Trends, 1975 to 2012, released yesterday by the Canadian Institute for Health Information (CIHI), show that the pace of growth is slowing.

Modest economic growth and budgetary deficits are having a moderating effect. For the third straight year, growth in health care spending will be less than that in the overall economy. The proportion of Canada's gross domestic product (GDP) spent on health care will reach (11.6% this year - down from 11.7% in 2011 and the all-time high of 11.9% in 2010.

"Provincial and territorial governments today are focused on controlling health care costs,” explains CIHI’s president and chief executive John Wright, adding: “Unlike in the past, they’re not cutting programs as much as looking at improving productivity, reducing overhead, controlling compensation and seeking value-for-money initiatives.”

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical